TNFRSF1B and type 1 diabetes mellitus: The group of Denise Faustman used an agonistic TNFR2-selective antibody to demonstrate that a subpopulation of insulin-specific CD8+, but not CD4+, T cells in blood samples from patients with type 1 diabetes was vulnerable to TNFR2 induced death.